IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cormorant Asset Management, LP

Q1 2024 Holdings

Filed 2024-05-15 | 57 holdings | $2.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Corbus Pharmaceuticals Hldgs(CRBP)COM NEW21833P301$79.5M2,025,0003.5%
Praxis Precision Medicines I(PRAX)COM NEW74006W207$79.9M1,310,0003.5%
Bridgebio Pharma Inc(BBIO)COM10806X102$99.0M3,203,0294.3%
Alpine Immune Sciences Inc(NVLSEUR)COM02083G100$107.0M2,700,0004.7%
Arcellx Inc(ACLX)COMMON STOCK03940C100$123.8M1,780,0005.4%
Eyepoint Pharmaceuticals Inc(EYPT)COM NEW30233G209$142.5M6,893,2356.3%
Moonlake Immunotherapeutics(MLTX)CLASS A ORD61559X104$426.7M8,494,15118.7%
PreviousPage 2 of 2